Hospital de Clínicas

Hospital de Clínicas de Porto Alegre (HCPA) is a prominent Brazilian teaching hospital and a public company under private law, affiliated with the Federal University of Rio Grande do Sul (UFRGS). Established in 1970, it serves as a premier center for high-complexity healthcare, medical education, and clinical research in South America. HCPA is globally recognized for its leadership in medical genetics and its extensive participation in international clinical trials, particularly in the fields of gene therapy for rare diseases and innovative oncology treatments. The institution's robust research infrastructure and academic environment make it a key partner for biotechnology and pharmaceutical companies seeking to conduct advanced clinical studies in Latin America. It operates as a semi-independent federal agency, maintaining a focus on healthcare excellence and scientific innovation while serving the Brazilian public health system.